Mobilise-D - Clinical Validation Study

  • Research type

    Research Study

  • Full title

    Validating digital mobility assessment using wearable technology – The Mobilise-D Clinical Validation Study.



  • Contact name

    Lynn Rochester

  • Contact email

  • Sponsor organisation

    The Newcastle upon Tyne Hospitals NHS Foundation Trust

  • Duration of Study in the UK

    2 years, 10 months, 1 days

  • Research summary

    The Mobilise-D Clinical Validation Study is the second study to be undertaken by the Mobilise-D project. The overall aim of this project is to develop a real world digital assessment of mobility. This Clinical Validation Study will use a technically validated body worn sensor to measure digital mobility outcomes and to predict relevant clinical outcomes. This assessment will obtain regulatory approval for future drug development and clinical practise.

    The Mobilise-D Clinical Validation study is a longitudinal observational cohort study conducted in ten different countries across 16 different sites. The study will enrol 2400 participants from four different disease cohorts; Chronic Obstructive Pulmonary Disease (COPD), Parkinson’s disease (PD), Multiple Sclerosis (MS) and Proximal femoral fracture (PFF).

    The study consists of a baseline visit, followed by four follow-up visits every six months. Each visit consists of the collection of descriptive, clinical, physical, neuropsychological and disease specific outcome measures. Following each visit, the participant is required to wear the body worn sensor for seven days continual monitoring. Falls and other clinical events will also be recorded between study visits.

  • REC name

    London - Bloomsbury Research Ethics Committee

  • REC reference


  • Date of REC Opinion

    15 Jan 2021

  • REC opinion

    Further Information Favourable Opinion